The U.S. Food and Drug Administration has paused Gilead Sciences' trials testing a combination of two of its experimental HIV ...

By bolstering immune cells, researchers at ViiV Healthcare in Branford have designed long-acting drugs that prevent infection ...

HALIFAX – Nova Scotia physicians and other sexual health experts who are calling on the provincial government to fund birth ...

A new injection to prevent HIV is expected to be approved by the U.S. Food and Drug Administration later this month.

It trades at 13.3 times forward earnings—below the industry average of 14, as measured by the NYSE Arca Pharmaceutical Index, ...

Gilead underscored its faith in the combo therapy and pledged to work with regulators to resolve the hold, which has paused ...

The medication, Lenacapavir, is said to have shown exceptional promise in clinical trials, and some of the research is being conducted here in Houston.

Last week, Montaner, who also heads the HIV/AIDS program at St. Paul’s Hospital and is the chair of AIDS research at UBC and ...

The Trump administration's cuts to the U.S. Agency for International Development have had reverberations around the world. The agency, which operated in over 100 nations and employed thousands of ...

A UVa researcher has discovered that NRTIs, drugs used to treat HIV, can also help prevent Alzheimer's and a long list of ...

The drug, Lenacapavir, has shown exceptional promise in clinical trials, including research conducted in Houston. In Harris County, new HIV cases are diagnosed at a significantly higher rate than ...